NEXTBio Capital Management LP bought a new stake in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 67,586 shares of the company’s stock, valued at approximately $7,234,000. Rhythm Pharmaceuticals makes up […]